Cryo Cell International CCEL Income Statement (2010-2026)

NYSE CCEL
$4.04 -0.06 (-1.45%)
As of: Sep 3, 2026 · 10:56 AM EDT
Reported Financials

Cryo Cell International Quarterly Income Statement

Periods 64 quarters
Latest May 2026

Cryo Cell International reported revenue of $7.78M and net income of $0.55M for the quarter ended May 2026, down 1.9% year over year. This income statement covers 64 quarters of results from Aug 2010 through May 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026
Revenue & cost
Revenue
7.50M7.32M7.26M7.63M7.68M7.76M7.82M7.77M7.87M7.88M7.85M8.04M8.07M8.02M7.97M7.93M7.83M7.84M7.68M7.78M
Cost of RevenueCost of Rev
2.46M2.30M2.10M2.20M2.35M2.14M2.07M2.14M2.16M2.02M2.07M2.02M2.13M1.64M1.98M1.86M1.80M1.73M1.66M1.68M
Gross Profit
5.04M5.02M5.16M5.43M5.33M5.63M5.76M5.63M5.71M5.85M5.79M6.02M5.94M6.39M5.98M6.07M6.02M6.11M6.03M6.10M
Operating items
Research & DevelopmentR&D
0.01M0.03M0.15M0.08M0.08M0.08M0.08M0.30M0.34M0.44M0.50M0.24M0.19M0.30M0.10M0.13M0.06M0.08M0.07M0.10M
Selling, General & AdministrativeSG&A
3.49M4.53M3.38M3.91M3.60M4.69M3.88M4.04M3.80M5.44M4.43M4.02M4.16M6.01M4.64M4.26M3.88M5.45M5.01M4.62M
Other Operating ExpensesOther Opex
2.40M3.56M2.26M2.45M3.04M2.59M2.18M2.40M2.56M18.16M2.10M2.39M2.32M1.83M2.18M2.05M1.99M6.28M1.84M1.86M
Operating ExpensesOpex
5.91M8.12M5.79M6.44M6.73M7.36M6.14M6.74M6.71M24.05M7.03M6.65M6.68M8.15M6.91M6.44M5.92M11.81M6.92M6.58M
Operating IncomeOp. Inc
1.60M-0.81M1.47M1.19M0.95M0.41M1.68M1.03M1.16M-16.18M0.82M1.39M1.39M-0.12M1.06M1.49M1.90M-3.97M0.77M1.20M
EBIT
1.60M-0.81M1.47M1.19M0.95M0.41M1.68M1.03M1.16M-16.18M0.82M1.39M1.39M-0.12M1.06M1.49M1.90M-3.97M0.77M1.20M
Non-operating items
Non Operating Interest Expenses
0.34M0.42M0.31M0.28M0.37M0.57M0.47M0.47M0.47M-0.17M0.26M0.33M0.53M0.75M0.49M0.55M0.54M0.48M0.46M0.44M
Non Operating Investment IncomeNon-Op. Investment Inc.
736.000.00M-0.01M-0.02M-0.01M-515.00-0.00M0.01M0.09M-0.05M0.27M0.26M0.52M0.02M-0.03M-0.38M-0.19M-0.20M-0.24M0.07M
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
25.0024.009.00118.000.06M0.38M0.00M-0.22M0.28M-0.26M-0.05M0.15M981.000.00M0.01M0.02M0.02M0.01M338.00
Non Operating IncomeNon Op. Inc.
-0.34M-0.44M-0.31M-0.29M-0.31M0.22M-0.47M-0.68M-0.09M0.18M-0.03M0.08M-0.01M-0.72M-0.52M-0.92M-0.71M-0.67M-0.69M-0.37M
Net income details
EBT
1.26M-1.24M1.16M0.90M0.64M0.62M1.21M0.35M1.07M-15.99M0.79M1.47M1.38M-0.84M0.53M0.58M1.19M-4.63M0.07M0.83M
Tax ProvisionsTaxes
0.40M2.40M0.32M0.27M0.17M0.81M0.45M0.13M0.39M-4.80M0.24M0.82M0.33M1.33M0.25M0.22M0.44M3.69M0.02M0.27M
Profit After TaxPAT
0.86M-0.64M0.83M0.63M0.47M0.84M0.77M0.22M0.68M-11.19M0.56M0.66M1.05M-1.86M0.28M0.36M0.75M-3.82M0.05M0.55M
Equity Income
Income from Continuing OperationsIncome (Continuing)
0.86M-3.64M0.83M0.63M0.47M-0.19M0.77M0.22M0.68M-11.19M0.56M0.66M1.05M-2.18M0.28M0.36M0.75M-8.32M0.05M0.55M
Consolidated Net IncomeConsol Net Inc.
0.86M-3.64M0.83M0.63M0.47M-0.19M0.77M0.22M0.68M-11.19M0.56M0.66M1.05M-2.18M0.28M0.36M0.75M-8.32M0.05M0.55M
Income towards Parent CompanyParent Net Inc
0.86M-3.64M0.83M0.63M0.47M-0.19M0.77M0.22M0.68M-11.19M0.56M0.66M1.05M-2.18M0.28M0.36M0.75M-8.32M0.05M0.55M
Net Income towards Common StockholdersNet Income
0.86M-3.64M0.83M0.63M0.47M-0.19M0.77M0.22M0.68M-11.19M0.56M0.66M1.05M-2.18M0.28M0.36M0.75M-8.32M0.05M0.55M
Additional items
EPS (Basic)
0.10-0.450.100.080.06-0.020.090.030.08-1.340.070.080.13-0.270.030.040.09-1.030.010.07
EPS (Diluted)
0.10-0.440.100.070.06-0.020.090.030.08-1.340.070.080.13-0.270.030.040.09-1.030.010.07
Shares Outstanding
8.45M8.14M8.53M8.44M8.39M8.47M8.47M8.33M8.29M8.34M8.28M8.12M8.06M8.13M8.08M8.08M8.06M8.07M8.06M8.06M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
8.69M8.36M8.75M8.55M8.40M8.48M8.47M8.33M8.34M8.34M8.33M8.23M8.17M8.21M8.20M8.13M8.07M8.07M8.06M8.06M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
8.53M8.56M8.49M8.40M8.53M8.50M8.44M8.29M8.29M8.29M8.25M8.06M8.06M8.08M8.08M8.06M8.06M8.06M8.06M8.06M
EBITDA
1.60M-0.81M1.47M1.19M0.95M0.41M1.68M1.03M1.16M-16.18M0.82M1.39M1.39M-0.12M1.06M1.49M1.90M-3.97M0.77M1.20M
Interest ExpensesInt Expense
0.34M0.42M0.31M0.28M0.37M0.57M0.47M0.47M0.47M-0.17M0.26M0.33M0.53M0.75M0.49M0.55M0.54M0.48M0.46M0.44M
Tax Rate
32.09%-192.88%28.00%29.46%27.17%130.14%36.86%36.21%36.25%30.03%29.99%55.45%23.78%-158.37%47.00%38.14%36.81%-79.63%33.00%33.00%